Atlanta Genitourinary Cancers Summit
The CME-accredited Atlanta Genitourinary Cancers Summit offers a multi-format educational experience focused on the latest advances in GU oncology, covering prostate, kidney, bladder, and rare cancers. Available as a live conference on March 15, 2025, a recorded webcast, and an interactive gamified activity, the summit is designed for oncologists, fellows, and other healthcare professionals. Through expert-led sessions, attendees will gain evidence-based insights into emerging treatments, guideline updates, and practical strategies via case-based discussions. The summit emphasizes personalized, patient-centered care, equipping practitioners with enhanced skills to improve outcomes and address disparities in cancer care across different learning formats.
Target Audience
Medical Oncologists
Surgical Oncologists
Radiation Oncologists
Oncology Fellows/Residents
Oncology Nurses
Nurse Practitioners
Physician Assistants
Oncology Pharmacists
Organizing Committee
Course Director:
Dr. Binay Shah - Binaytara Foundation
Conference Chairs:
Dr. Mehmet Asim Bilen - Emory University
Dr. Yousef Zakharia - Mayo Clinic
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Review current standards and evolving strategies for the management of both localized and advanced genitourinary malignancies.
- Incorporate practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with genitourinary cancers.
- Select treatment plans based on patient and disease factors.
- Compare and contrast the safety and efficacy profiles of various therapeutic strategies to enhance decision-making in the management of patients with genitourinary cancers
March 15th, 2025
All times set in Eastern Daylight Time (EDT)
07:00 AM – 08:00 AM Breakfast, Registration, & Exhibits
08:00 AM – 08:05 AM Welcome
08:05 AM – 08:30 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:30 AM – 10:00 AM Session 1: Prostate Cancer
Session Chair: Bradley Carthon, MD
08:30 AM – 08:50 AM Current Treatment Landscape for mHSPC - Chandler Park, MD
08:50 AM – 09:10 AM Treatment Updates in mCRPC - Rohan Garje, MD
09:10 AM – 10:00 AM Case-Based Discussion - Jordan Ciuro, MD
10:00 AM – 10:30 AM Break & Exhibits
10:30 AM – 12:00 PM Session 2: Kidney Cancer
Session Chair: Mehmet Asim Bilen, MD
10:30 AM – 10:50 AM Evolving Landscape of Treatment for First Line mRCC - Pedro Barata, MD, MSc, FACP
10:50 AM – 11:10 AM Current and Emerging Treatments in Non-Clear Cell RCC and Subsequent Line Advanced Clear-Cell RCC - Benjamin Maughan, MD, PharmD
11:10 AM – 12:00 PM Case-Based Discussion - Shahid Ahmed, MD, MBBS
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 02:30 PM Session 3: Bladder Cancer
Session Chair: Shreyas Joshi, MD, MPH
01:00 PM – 01:20 PM Guideline Recommended Care in mUC - Rohit Jain, MD
01:20 PM – 01:40 PM Emerging Treatment Options for MIBC - Arnab Basu, MD, MPH, FACP
01:40 PM – 02:30 PM Case-Based Discussion - Jacqueline Brown, MD
02:30 PM – 03:00 PM Break & Exhibits
03:00 PM – 04:30 PM Session 4: Rare Tumors
Session Chair: Vikram Narayan, MD
03:00 PM – 03:20 PM Management of Penile Cancer - Viraj Master, MD, PhD, FACS
03:20 PM – 03:40 PM Novel Treatment Approaches for ACC - Matt Campbell, MD, MS
03:40 PM – 04:30 PM Case-Based Discussion - Bassel Nazha, MD, MPH
04:30 PM Adjourn
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Mehmet Bilen, MD
Yousef Zakharia, MD
Mehmet Bilen, MD
Shreyas Joshi
Yousef Zakharia, MD
Pedro Barata, MD, MSc, FACP
Arnab Basu, MD, MPH
Matthew Campbell, MD, MS
Benjamin Maughan, M.D., PharmD
Chandler Park, Medical Doctor, Masters in Science
Shahid Ahmed
Jordan Ciuro, MD
Bassel Nazha, MD, MPH
Acknowledgement of Commercial Support
This activity is supported with an Independent Medical Education Grant from:
- Pfizer
Available Credit
- 6.00 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 6.00 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 6.00 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.